fluorodeoxyglucose f18 has been researched along with dabrafenib in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlino, MS; Haydu, LE; Kefford, RF; Lebowitz, PF; Long, GV; Martin Curtis, C; Menzies, AM; Saunders, CA | 1 |
| Broski, SM; Glazebrook, KN; Moran, EK; Nathan, MA | 1 |
| Banzo, I; García-Castaño, A; Jiménez-Bonilla, J; Martínez-Rodríguez, I; Quirce, R | 1 |
| Allen, SW; Close, A; Mastropolo, R; Maurer, S; McClain, KL; Picarsic, J | 1 |
1 trial(s) available for fluorodeoxyglucose f18 and dabrafenib
| Article | Year |
|---|---|
(18)F-labelled fluorodeoxyglucose-positron emission tomography (FDG-PET) heterogeneity of response is prognostic in dabrafenib treated BRAF mutant metastatic melanoma.
Topics: Adult; Dose-Response Relationship, Drug; Female; Fluorodeoxyglucose F18; Humans; Imidazoles; Male; Melanoma; Mutation; Oximes; Positron-Emission Tomography; Prognosis; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Radiopharmaceuticals; Survival Analysis; Treatment Outcome | 2013 |
3 other study(ies) available for fluorodeoxyglucose f18 and dabrafenib
| Article | Year |
|---|---|
BRAF Inhibitor-Induced Panniculitis: Appearance on 18F-FDG PET/CT.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Imidazoles; Indoles; Male; Melanoma; Multimodal Imaging; Neoplasm Metastasis; Oximes; Panniculitis; Positron-Emission Tomography; Proto-Oncogene Proteins B-raf; Radiopharmaceuticals; Sulfonamides; Tomography, X-Ray Computed; Vemurafenib | 2016 |
Erythema Nodosum-Like Panniculitis as a False-Positive 18F-FDG PET/CT in Advanced Melanoma Treated With Dabrafenib and Trametinib.
Topics: Adult; Antineoplastic Agents; Erythema Nodosum; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Imidazoles; Melanoma; Oximes; Panniculitis; Positron Emission Tomography Computed Tomography; Pyridones; Pyrimidinones; Radiopharmaceuticals | 2017 |
Topics: Adult; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Histiocytosis, Langerhans-Cell; Histiocytosis, Sinus; Humans; Imidazoles; Infant; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Oximes; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Treatment Outcome | 2019 |